AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

Find the latest Drugs in Development and Pipeline Prospector News of Optime Care.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Optime Care
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
4060 Wedgeway Court Earth City, Missouri 63045
Telephone
Telephone
(888) 287-2017
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Rezlidhia (olutasidenib) is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test.


Lead Product(s): Olutasidenib

Therapeutic Area: Oncology Product Name: Rezlidhia

Highest Development Status: ApprovedProduct Type: Small molecule

Recipient: Rigel Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership December 13, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY